BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15233928)

  • 1. Moxonidine and rilmenidine injected into the medial septal area reduces the salivation induced by pilocarpine.
    Saad WA; de Arruda Camargo LA; Simões S; Saad WA; Guarda RS; Guarda IF
    Auton Neurosci; 2004 May; 112(1-2):31-6. PubMed ID: 15233928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central alpha(2) adrenergic receptors and cholinergic-induced salivation in rats.
    Takakura AC; dos Santos Moreira T; De Luca LA; Renzi A; Menani JV
    Brain Res Bull; 2003 Jan; 59(5):383-6. PubMed ID: 12507689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of alpha(2)-adrenoceptors in the lateral hypothalamus reduces pilocarpine-induced salivation in rats.
    Takakura AC; Moreira TS; Colombari DS; De Luca LA; Menani JV
    Neurosci Lett; 2009 Feb; 450(3):225-8. PubMed ID: 19041371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pilocarpine-induced salivation in rats by central noradrenaline.
    Moreira Tdos S; Takakura AC; De Luca LA; Renzi A; Menani JV
    Arch Oral Biol; 2002 Jun; 47(6):429-34. PubMed ID: 12102758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxonidine reduces pilocarpine-induced salivation in rats.
    Moreira TS; Thomaz AC; De Luca LA; Renzi A; Menani JV
    Auton Neurosci; 2001 Aug; 91(1-2):32-6. PubMed ID: 11515799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the medial septal area on pilocarpine-induced salivary secretion and water intake.
    Paulin RF; Menani JV; Colombari E; De Paula PM; Colombari DS
    Brain Res; 2009 Nov; 1298():145-52. PubMed ID: 19728997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are imidazoline receptors involved in sympathetic neurotransmission in rat vas deferens?
    Avellar MC; Markus RP
    Gen Pharmacol; 1996 Oct; 27(7):1273-8. PubMed ID: 8981080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel evidence that nitric oxide of the medial septal area influences the salivary secretion induced by pilocarpine.
    Saad WA; Guarda IF; Camargo LA; dos Santos TA; Saad WA; Simões S; Guarda RS
    Life Sci; 2002 Apr; 70(20):2403-12. PubMed ID: 12150204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of forebrain imidazoline and alpha(2)-adrenergic receptors in the antidipsogenic response to moxonidine.
    Andrade CA; Oliveira LB; Martinez G; Silva DC; De Luca LA; Menani JV
    Ann N Y Acad Sci; 2003 Dec; 1009():262-4. PubMed ID: 15028596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of sympathoinhibition by imidazolines.
    Szabo B; Urban R
    Ann N Y Acad Sci; 1995 Jul; 763():552-65. PubMed ID: 7677373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of central alpha1-adrenoceptors on renal responses to central moxonidine and alpha-methylnoradrenaline.
    de Andrade CA; de Andrade GM; De Paula PM; De Luca LA; Menani JV
    Eur J Pharmacol; 2009 Apr; 607(1-3):60-7. PubMed ID: 19326476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for functional imidazoline receptors on locus coeruleus neurons.
    Szabo B; Fröhlich R; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):557-63. PubMed ID: 8740150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central moxonidine on water and NaCl intake.
    Menani JV; Sato MA; Haikel L; Vieira AA; de Andrade CA; da Silva DC; Renzi A; De Luca LA
    Brain Res Bull; 1999 Jul; 49(4):273-9. PubMed ID: 10424847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine.
    Chan CK; Head GA
    J Hypertens; 1996 Jul; 14(7):855-64. PubMed ID: 8818924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
    Szabo B; Bock C; Nordheim U; Niederhoffer N
    Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damage of the medial preoptic area impairs peripheral pilocarpine-induced salivary secretion.
    Lopes de Almeida R; De Luca LA; de Almeida Colombari DS; Menani JV; Renzi A
    Brain Res; 2006 Apr; 1085(1):144-8. PubMed ID: 16580646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
    Mammoto T; Kamibayashi T; Hayashi Y; Yamatodani A; Takada K; Yoshiya I
    Br J Pharmacol; 1996 Apr; 117(8):1744-8. PubMed ID: 8732285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.